Abstract
We hypothesized that, by inhibiting myocardial late Na+ current, Ranolazine improves angina symptoms, exercise tolerance and coronary microvascular function in patients with microvascular ischemia. In this pilot randomized, double-blinded, placebo-controlled trial, 24 patients with angina symptoms
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have